NTT Com Launches Enterprise Cloud WebRTC Platform Globally
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), announced today the global launch of its Enterprise Cloud WebRTC Platform (ECL WebRTC), a service enabling the same-day deployment of online real-time communication functions such as voice & video communications and data transmission capabilities on smartphones, tablets and web applications.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170912005815/en/
Figure (Graphic: Business Wire)
The ECL WebRTC platform offers the following benefits:
- Software Development Kits (SDKs), offering video, voice and data transmission capabilities; the service will deliver four kinds of SDKs compatible with web browsers, iOS, Android or IoT.
- By equipping applications and websites with ECL WebRTC, customers can quickly deploy real-time communication functions such as multi-person video & voice conferencing, as well as data transmission.
- NTT Com supplies and operates all server infrastructure required for WebRTC; customers can focus on their own service development and delivery.
- The service will be made available to enterprises via a subscription plan providing full technical support and a Service Level Agreement offering 99.99% availability; start-up enterprises and developers can sign up online for free-of-charge plans offering limited capacity usage (please see the Appendix for more information).
ECL WebRTC is an NTT Com service that operates servers required for the use of Web Real-Time Communication (WebRTC) capabilities, the standardized technology to realize real-time communication, and that provides software development kit (SDK). WebRTC is a technology that allows web browsers and iOS, Android or IoT devices to send and receive real-time media, demand for which has been driven by the increase in remote working, teleconferencing and distance learning, as well as the growth of online call centers and online translation. In 2013 NTT Com launched SkyWay, Japan’s first WebRTC platform, now used by approximately 5,000 developers, 8,000 applications and 300,000 users. To meet the evolving needs of the marketplace, NTT Com has now launched ECL WebRTC, a fully-fledged commercial service based on the technologies used in SkyWay.
Enterprise Cloud WebRTC Platform Official Site
NTT Communications to Release Trial of SkyWay WebRTC Platform with
TURN Feature (press release on January 27, 2015):
NTT Communications Offers World’s 1st Speech-Recognition API for
Multiple Browsers at No Charge (press release on July 28, 2015):
About NTT Communications Corporation
NTT Communications provides consultancy, architecture, security and
cloud services to optimize the information and communications technology
(ICT) environments of enterprises. These offerings are backed by the
company’s worldwide infrastructure, including the leading global tier-1
IP network, the Arcstar Universal One™ VPN network reaching 196
countries/regions, and 140 secure data centers worldwide. NTT
Communications’ solutions leverage the global resources of NTT Group
companies including Dimension Data, NTT DOCOMO and NTT DATA.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com | LinkedIn@NTT Com
Functions of ECL WebRTC (SDK/Server API)
Server API: Signaling, STUN, TURN, SFU (optional services)
Signaling: exchanges information including IP address and port numbers required for connection between devices.
STUN: obtains global IP address and port numbers of the device.
TURN: enables the use of WebRTC in network environments where P2P communication cannot be used, such as enterprise networks, via data relaying.
SFU: A type of media server that distributes data received from one device to other devices and enables communication between a greater number of people. SFU reduces encoding load on the device and bandwidth, as well as the quantity of sent data when communication is with more than three people.
IoT SDK β version: SDK for developing Linux/Raspberry Pi applications.
|Fee-Liable Plans||Free of Charge Plans|
|Price||Basic||2.480JPY per min, with an upper limit of 100,000 JPY per month*||-|
Free of charge for up to one million events, 100,000 JPY thereafter
|TURN/SFU||40 JPY/GB per one In/Out||-|
|Limit of use||Number of times of Signaling||-||Up to 500,000 times per month|
|Amount of TURN||-||500GB per month|
|Amount of SFU||-||500GB per month|
|Support||Ticket support and developers’ community||Developers’ community only|
* The basic fee will be charged for each tenant. Customers can make more than one API key for WebRTC in each tenant.
Mr. Yasumasa Morita / Mr. Masayuki Hayashi / Ms. Yuko Tomita, +81 3 6733 9521
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million20.11.2017 08:43 | Pressemelding
LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failures. CRM products include high-voltage defibrillators, cardiac resynchronization therapy devices and low-voltage pacemakers. The CRM Business Franchise generated approximately $249 million in net sales in fiscal year 2016 and has approximately 900 employees with operations chiefly in Clamart, France; Saluggia, Italy; and Santo Domingo, Dominican Republic. MicroPort is a leading medical device company, focused on innova
Chugai's Bispecific Antibody Emicizumab Meets Primary Endpoint in Phase lll Study20.11.2017 08:29 | Pressemelding
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the primary endpoint has been met for the global phase lll HAVEN 3 (NCT02847637) study evaluating emicizumab (ACE910) subcutaneous injection, once a week and once every two weeks, in patients with hemophilia A (12 years of age or older) without inhibitors to factor Vlll. A statistically significant reduction in the number of bleeds was confirmed in patients treated with emicizumab prophylaxis compared to those receiving no prophylactic treatment. The study also met a secondary endpoint that once-weekly emicizumab prophylaxis was superior to factor VIII prophylaxis, as demonstrated by a statistically significant and clinically meaningful reduction in treated bleeds in an intra-patient comparison of patients receiving emicizumab prophylaxis compared to their prior factor VIII prophylaxis. The most common adverse events with em
Fiorano Launches PSD2 Solution for Banks for Seamless Regulatory Compliance20.11.2017 08:00 | Pressemelding
Fiorano Software, a proven global leader in Integration Middleware and API Management, today announced the launch of Fiorano PSD2, a platform solution enabling banks to comply with the European Union’s Revised Payment Service Directive (PSD2) regulations. Fiorano’s end-to-end PSD2 solution is built on the industry's leading banking Integration and API Management infrastructure serving as an onramp for future eDigital Banking initiatives. Banks across Europe need to be PSD2 compliant by January 2018. They are also facing severe competition from FinTechs to improve online payments, customer engagement experiences and making cross-border payments safer. “By building on PSD2 as a solution on top of a tightly integrated API Management and ESB platform, Fiorano masks complex technical details, dramatically simplifies the time and effort for compliance,” said Mr. Atul Saini, CEO of Fio
Synteract Thought Leaders to Speak & Exhibit at Partnerships in Clinical Trials Europe in Amsterdam20.11.2017 08:00 | Pressemelding
(Booth #17) – Thought leaders from Synteract, a full-service, international contract research organization (CRO), will exhibit and present at Partnerships in Clinical Trials Europe (PCT), November 28-29, Amsterdam, Netherlands. With awareness of the shifting CRO landscape and the complexity this represents to biopharma companies as they make critical outsourcing decisions, Synteract invites attendees to “Pause to rethink what matters most from your CRO.” Vice President, Global Medical and Regulatory Affairs at Synteract, Dr. Martine Dehlinger-Kremer, will speak on “The EU Clinical Trials Regulation: Are you prepared for its implementation?” at the event on Tuesday, November 28 at noon. She will address how evolving industry needs are driving momentum towards implementation of a new regulation governing clinical trials, the expected impact on sponsors and necessary steps toward p
Record Attendance at Japan Content Showcase 2017!20.11.2017 03:00 | Pressemelding
Japan Content Showcase 2017 was held October 23-26 at Ikebukuro Sunshine City and the Shibuya Excel Hotel Tokyu. A record 19,549 people participated in sales meetings, excluding the TIMM Showcase Live. Other new records this year were 371 exhibiting groups from 27 countries and regions and 1,549 buyers from 48 countries and regions. There was a significant increase in overseas buyers this year, the 1022 foreign registrations representing an increase of more than 10% over last year. The number of non-Japanese Asian buyers increased by 6%, North Americans by 13%, South Americans by 44%, and Europeans by 49%. The number of Middle Eastern buyers doubled, and there were more than five times the number of Russian buyers as last year. French buyers were up 70%, Italians 60%, British 75%, and Germans 50%. Business matching was a new service offered by the organizers this year. Meeti
Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses20.11.2017 00:01 | Pressemelding
Shell and bio-bean announce that together they are helping to power some of London’s buses using a biofuel made partly from waste coffee grounds. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005060/en/ Shell and bio-bean announce that together they are helping to power some of London's buses using a biofuel made partly from waste coffee grounds (Photo: Business Wire) The B20 biofuel contains a 20% bio-component which contains part coffee oil. The biofuel is being added to the London bus fuel supply chain and will help to power some of the buses; without need for modification. Biofuel provides a cleaner, more sustainable energy solution for buses across London’s network by decreasing emissions1. “Our Coffee Logs have already become the fuel of choice for households looking for a
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom